{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:00:08Z","timestamp":1787320808309,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early in the 2022 mpox outbreak, the US recommendation was to administer two doses of the JYNNEOS vaccine 4\u00a0weeks apart. However, because of limited vaccine supply, New York City (NYC) prioritized single dose vaccination. We estimated mpox cases averted by this strategy compared to strategies that prioritized 2-dose vaccination for a smaller portion of the population. We fit a network transmission model to incident mpox cases in NYC. Model output consisted of predicted cases over time when vaccine doses were administered with the \u201cfirst-dose priority\u201d strategy, compared with counterfactual simulations, where doses were administered to those eligible for a second dose ahead of those waiting for a first dose (\u201cintermediate\u201d strategy), or where individuals were preallocated full courses of the vaccine (\u201csecond-dose priority\u201d strategy). We estimate that NYC\u2019s strategy averted 66% (IQR, 47%-78%) of potential mpox cases compared to no vaccination. This \u201cfirst-dose priority\u201d strategy averted 0.6% (IQR, \u221211% to 9.8%) more cases than the \u201cintermediate\u201d strategy, and 17% (IQR, 2.9%-38%) more cases than the \u201csecond-dose priority\u201d strategy. Thus, for the 2022 mpox outbreak in NYC, preallocating vaccine doses to ensure full vaccination in a high-priority subset of the population would have increased the size of the outbreak.<\/jats:p>","DOI":"10.1093\/aje\/kwaf054","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:21:19Z","timestamp":1741652479000},"page":"948-955","source":"Crossref","is-referenced-by-count":3,"title":["Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3491-9985","authenticated-orcid":false,"given":"Patrick A","family":"Clay","sequence":"first","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-9817","authenticated-orcid":false,"given":"Emily D","family":"Pollock","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8879-6354","authenticated-orcid":false,"given":"Enrique M","family":"Saldarriaga","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-6079","authenticated-orcid":false,"given":"Preeti","family":"Pathela","sequence":"additional","affiliation":[{"name":"Disease Control, New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV, and STI , Queens, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-9903","authenticated-orcid":false,"given":"Michelle","family":"Macaraig","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1228-6387","authenticated-orcid":false,"given":"Jane R","family":"Zucker","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene , New York, NY ,","place":["United States"]},{"name":"National Center for Influenza and Respiratory Diseases, Immunization Services Division, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4288-2134","authenticated-orcid":false,"given":"Bindy","family":"Crouch","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-9466","authenticated-orcid":false,"given":"Ian","family":"Kracalik","sequence":"additional","affiliation":[{"name":"National Center for Emerging and Zoonotic Infectious Diseases, Division of High Consequence Pathogens and Pathology, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5558-6350","authenticated-orcid":false,"given":"Ian H","family":"Spicknall","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC , Atlanta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2026041002350038700_ref1","author":"Interim Clinical Considerations for Use of Vaccine for Mpox Prevention in the United States"},{"key":"2026041002350038700_ref2","author":"NYC Health Department on Monkeypox Vaccination Strategy and Prioritization of First Doses"},{"issue":"21","key":"2026041002350038700_ref3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.15585\/mmwr.mm7221a1","article-title":"Potential for recurrent Mpox outbreaks among gay, bisexual, and other men who have sex with men\u2014United States, 2023","volume":"72","author":"Pollock","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"19","key":"2026041002350038700_ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.15585\/mmwr.mm7319a3","article-title":"Preparedness and response to increasing clade I Mpox cases in the Democratic Republic of the Congo\u2014United States, 2024","volume":"73","author":"McQuiston","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"35","key":"2026041002350038700_ref5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.15585\/mmwr.mm7135e2","article-title":"Modeling the impact of sexual networks in the transmission of Monkeypox virus among gay, bisexual, and other men who have sex with men\u2014United States, 2022","volume":"71","author":"Spicknall","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"2026041002350038700_ref6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/sextrans-2023-055922","article-title":"Modelling the impact of vaccination and sexual behaviour adaptations on mpox cases in the USA during the 2022 outbreak","volume":"100","author":"Clay","year":"2024","journal-title":"Sex Transm Infect."},{"key":"2026041002350038700_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2020.100386","article-title":"Egocentric sexual networks of men who have sex with men in the United States: results from the ARTnet study","volume":"30","author":"Weiss","year":"2020","journal-title":"Epidemics."},{"issue":"5","key":"2026041002350038700_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28769","article-title":"Presymptomatic viral shedding in high-risk mpox contacts: a prospective cohort study","volume":"95","author":"Brosius","year":"2023","journal-title":"J Med Virol."},{"issue":"10","key":"2026041002350038700_ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007791","article-title":"A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy","volume":"13","author":"Beer","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"issue":"35","key":"2026041002350038700_ref10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.15585\/mmwr.mm7135e1","article-title":"Strategies adopted by gay, bisexual, and other men who have sex with men to prevent Monkeypox virus transmission\u2014United States, August 2022","volume":"71","author":"Delaney","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2026041002350038700_ref11","author":"New York City Department of Health and Mental Hygeine"},{"key":"2026041002350038700_ref12","author":"FACT SHEET: Biden-Harris Administration\u2019s Monkeypox Outbreak Response | The White House"},{"issue":"20","key":"2026041002350038700_ref13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing Mpox: a multijurisdictional case-control study\u2014United States, August 19, 2022\u2013March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"26","key":"2026041002350038700_ref14","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against Mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med."},{"key":"2026041002350038700_ref15","volume-title":"Presented at: 2024 STI Prevention Conference","author":"Saldarriaga"},{"key":"2026041002350038700_ref16","author":"EpiQuery - Community Health Survey 2020: NYC Department of Health and Mental Hygeine"},{"key":"2026041002350038700_ref17","first-page":"2022","article-title":"Estimating the incubation period of monkeypox virus during the 2022 multi-national outbreak","author":"Charniga","year":"2022","journal-title":"medRxiv."},{"issue":"4","key":"2026041002350038700_ref18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med."},{"key":"2026041002350038700_ref19","author":"Mpox Vaccination"},{"key":"2026041002350038700_ref20","author":"WHO Director-General declares mpox outbreak a public health emergency of international concern"},{"issue":"10","key":"2026041002350038700_ref21","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J Gen Virol."},{"issue":"43","key":"2026041002350038700_ref22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15585\/mmwr.mm7143e2","article-title":"Receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox\u2014United States, May 22\u2013October 10, 2022","volume":"71","author":"Kriss","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2026041002350038700_ref23","author":"Vaccination | Mpox | Poxvirus | CDC"},{"issue":"25","key":"2026041002350038700_ref24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.15585\/mmwr.mm7025e2","article-title":"COVID-19 vaccination coverage and intent among adults aged 18\u201339 years\u2014United States, March\u2013May 2021","volume":"70","author":"Baack","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"9","key":"2026041002350038700_ref25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/OLQ.0000000000000332","article-title":"Heterogeneity of HIV prevalence among the sexual networks of Black and White MSM in Atlanta: illuminating a mechanism for increased HIV risk for young Black MSM","volume":"42","author":"Hern\u00e1ndez-Romieu","year":"2015","journal-title":"Sex Transm Dis."},{"issue":"10380","key":"2026041002350038700_ref26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet."},{"issue":"1","key":"2026041002350038700_ref27","first-page":"1","article-title":"Estimated HIV incidence and prevalence in the United States 2010\u20132019","volume":"26","author":"Linley","year":"2021","journal-title":"HIV Surveill Rep, Suppl Rep."},{"issue":"1","key":"2026041002350038700_ref28","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.5365","article-title":"Estimating the population sizes of men who have sex with men in US states and counties using data from the American Community Survey","volume":"2","author":"Grey","year":"2016","journal-title":"JMIR Public Health Surveill."},{"issue":"1","key":"2026041002350038700_ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29317","article-title":"Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination","volume":"96","author":"Sister\u00e9-Or\u00f3","year":"2024","journal-title":"J Med Virol."},{"issue":"26","key":"2026041002350038700_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126409","article-title":"MVA-BN vaccine effectiveness: a systematic review of real-world evidence in outbreak settings","volume":"42","author":"Mason","year":"2024","journal-title":"Vaccine."},{"key":"2026041002350038700_ref31","author":"Adult Immunization Schedule\u2013Healthcare Providers | CDC"},{"issue":"3","key":"2026041002350038700_ref32","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/S2468-2667(22)00337-1","article-title":"Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study","volume":"8","author":"Imai","year":"2023","journal-title":"Lancet Public Health."},{"issue":"1","key":"2026041002350038700_ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23761-1","article-title":"Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination","volume":"12","author":"Matrajt","year":"2021","journal-title":"Nat Commun."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwaf054\/62382297\/kwaf054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/195\/4\/948\/62382297\/kwaf054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/195\/4\/948\/62382297\/kwaf054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:35:06Z","timestamp":1775802906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/195\/4\/948\/8071272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,11]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwaf054","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,3,11]]}}}